Published in J Pediatr Gastroenterol Nutr on April 01, 2012
Extra-intestinal and long term consequences of Giardia duodenalis infections. World J Gastroenterol (2013) 1.17
Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments. World J Gastroenterol (2014) 0.89
Irritable bowel syndrome and migraine: bystanders or partners? J Neurogastroenterol Motil (2013) 0.87
More negative self-esteem and inferior coping strategies among patients diagnosed with IBS compared with patients without IBS--a case-control study in primary care. BMC Fam Pract (2015) 0.83
It's a gut feeling: how the gut microbiota affects the state of mind. J Physiol (2014) 0.83
Impact of psychological stress on irritable bowel syndrome. World J Gastroenterol (2014) 0.82
Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis. Curr Neuropharmacol (2016) 0.81
Maternal Weaning Modulates Emotional Behavior and Regulates the Gut-Brain Axis. Sci Rep (2016) 0.76
Aspects of the non-pharmacological treatment of irritable bowel syndrome. World J Gastroenterol (2015) 0.76
The role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspective. Therap Adv Gastroenterol (2015) 0.76
Irritable Bowel Syndrome Increases the Risk of Epilepsy: A Population-Based Study. Medicine (Baltimore) (2015) 0.75
Linaclotide. Hosp Pharm (2013) 0.75
Brain-Gut Axis Modulation of Acupuncture in Functional Dyspepsia: A Preliminary Resting-State fcMRI Study. Evid Based Complement Alternat Med (2015) 0.75
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study. J Neurogastroenterol Motil (2017) 0.75
Functional bowel disorders. Gastroenterology (2006) 20.72
Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med (2011) 10.03
Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology (2006) 5.73
The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology (2007) 5.04
Simplified assessment of segmental colonic transit. Gastroenterology (1987) 4.59
Chronic constipation. N Engl J Med (2003) 4.58
Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ (2008) 4.12
An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol (2009) 3.99
Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology (1995) 3.95
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut (2008) 3.92
A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med (2008) 3.91
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut (2008) 3.81
The need for large-scale randomized evidence without undue emphasis on small trials, meta-analyses, or subgroup analyses. JAMA (2009) 3.58
Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology (2002) 3.50
Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology (2010) 3.32
Postinfectious irritable bowel syndrome. Gastroenterology (2009) 3.17
Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One (2010) 3.03
Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol (2005) 2.99
A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. Am J Gastroenterol (2011) 2.81
Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2009) 2.73
Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology (1997) 2.39
SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents. Am J Physiol Cell Physiol (2004) 2.33
The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med (2000) 2.31
Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Gastroenterology (2007) 2.30
A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol (2009) 2.25
Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol (2010) 2.23
Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome. J Pediatr (2008) 2.15
Alterations in rectal sensitivity and motility in childhood irritable bowel syndrome. Gastroenterology (2001) 2.09
Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies. Aliment Pharmacol Ther (2008) 2.06
Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology (2005) 2.05
Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials. Dis Colon Rectum (2008) 2.04
Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2008) 1.93
Biofeedback training in treatment of childhood constipation: a randomised controlled study. Lancet (1996) 1.92
Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol (2007) 1.90
Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol (2009) 1.87
Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology (2009) 1.86
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. Aliment Pharmacol Ther (2009) 1.83
Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain (2009) 1.80
Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol (2001) 1.79
Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr (2008) 1.77
Regional gray matter density changes in brains of patients with irritable bowel syndrome. Gastroenterology (2010) 1.75
The brain-gut axis in abdominal pain syndromes. Annu Rev Med (2011) 1.68
The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol (2009) 1.65
Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology (2001) 1.64
Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation. Gastroenterology (2010) 1.61
A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol (2009) 1.60
Cow's-milk allergy is a risk factor for the development of FGIDs in children. J Pediatr Gastroenterol Nutr (2011) 1.58
Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility. Clin Gastroenterol Hepatol (2008) 1.57
Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study. Aliment Pharmacol Ther (2010) 1.56
Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology (2010) 1.53
Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol (2008) 1.52
Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome. Gut (2007) 1.50
Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology (2007) 1.48
Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol (2008) 1.47
Henoch-Schonlein purpura leads to functional gastrointestinal disorders. Dig Dis Sci (2010) 1.43
Developing irritable bowel syndrome guidelines through meta-analyses: does the emperor really have new clothes? Gastroenterology (2009) 1.43
What is the meaning of colorectal transit time measurement? Dis Colon Rectum (1992) 1.39
Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial. Gastroenterology (2007) 1.38
Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls. Am J Physiol Gastrointest Liver Physiol (2011) 1.38
Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. Am J Gastroenterol (2011) 1.33
Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome. Aliment Pharmacol Ther (2008) 1.32
Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut (2011) 1.31
VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr (2010) 1.29
Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study. Neurogastroenterol Motil (2009) 1.27
A systematic review of neuroimaging data during visceral stimulation. Am J Gastroenterol (2003) 1.25
A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome. Scand J Gastroenterol (2008) 1.22
A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology (2011) 1.22
Visceral hyperalgesia in children with functional abdominal pain. J Pediatr (2001) 1.21
Prognosis of constipation: clinical factors and colonic transit time. Arch Dis Child (2004) 1.19
Towards a molecular risk map--recent advances on the etiology of inflammatory bowel disease. Semin Immunol (2009) 1.18
Randomised clinical trial: The ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation--a double-blind study. Aliment Pharmacol Ther (2011) 1.16
Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies. Aliment Pharmacol Ther (2010) 1.16
Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther (2011) 1.15
A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrhea-predominant irritable bowel syndrome. Digestion (2008) 1.15
Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation. Neurogastroenterol Motil (2009) 1.14
Mechanisms in IBS: something old, something new, something borrowed... Neurogastroenterol Motil (2005) 1.13
Somatic referral of visceral sensations and rectal sensory threshold for pain in children with functional gastrointestinal disorders. J Pediatr (2007) 1.13
Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. Am J Physiol Gastrointest Liver Physiol (2003) 1.13
Psychosocial interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev (2008) 1.12
Mechanisms of intestinal gas retention in humans: impaired propulsion versus obstructed evacuation. Am J Physiol Gastrointest Liver Physiol (2001) 1.12
Gastrointestinal transit abnormalities are frequently detected in patients with unexplained GI symptoms at a tertiary centre. Neurogastroenterol Motil (2007) 1.09
Post-infectious functional gastrointestinal disorders in children. J Pediatr (2008) 1.05
Efficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndrome. Clin Gastroenterol Hepatol (2007) 1.04
A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome--a randomized controlled trial with primary care physicians. Neurogastroenterol Motil (2008) 1.02
Effects of pregabalin on visceral pain responses and colonic compliance in rats. Br J Pharmacol (2008) 1.01
Symptom severity but not psychopathology predicts visceral hypersensitivity in irritable bowel syndrome. Clin Gastroenterol Hepatol (2008) 1.01
Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis. Neurogastroenterol Motil (2011) 0.97
Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in children and adolescents. Cochrane Database Syst Rev (2011) 0.97
Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev (2008) 0.97
Effects of the N-methyl-D-aspartate receptor on temporal summation of second pain (wind-up) in irritable bowel syndrome. J Pain (2010) 0.96
Audio-recorded guided imagery treatment reduces functional abdominal pain in children: a pilot study. Pediatrics (2009) 0.95
A pilot study of motility and tone of the left colon in patients with diarrhea due to functional disorders and dysautonomia. Am J Gastroenterol (1997) 0.94
GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome. Neurogastroenterol Motil (2008) 0.93
New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders. Expert Opin Investig Drugs (2010) 0.93
Irritable bowel syndrome in childhood: visceral hypersensitivity and psychosocial aspects. Neurogastroenterol Motil (2009) 0.93
Taking a lesson from microbial diarrheagenesis in the management of chronic constipation. Gastroenterology (2010) 0.92
Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology (2006) 5.73
Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr (2009) 3.66
The Paris Consensus on Childhood Constipation Terminology (PACCT) Group. J Pediatr Gastroenterol Nutr (2005) 2.53
Recurrent abdominal pain, anxiety, and depression in primary care. Pediatrics (2004) 2.07
Chronic intestinal pseudo-obstruction: assessment and management. Gastroenterology (2006) 1.91
Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology (2009) 1.86
Chronic abdominal pain in children: a clinical report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr (2005) 1.81
Colonic manometry in children with defecatory disorders. role in diagnosis and management. Am J Gastroenterol (2003) 1.79
Epidemiology of constipation in children and adults: a systematic review. Best Pract Res Clin Gastroenterol (2011) 1.77
Gastrointestinal motility and sensory abnormalities may contribute to food refusal in medically fragile toddlers. J Pediatr Gastroenterol Nutr (2003) 1.75
Psychological comorbidity and stress reactivity in children and adolescents with recurrent abdominal pain and anxiety disorders. J Am Acad Child Adolesc Psychiatry (2003) 1.69
A prospective school-based study of abdominal pain and other common somatic complaints in children. J Pediatr (2008) 1.63
Chronic Abdominal Pain In Children: a Technical Report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr (2005) 1.51
Cold reperfusion before rewarming reduces neurological events after deep hypothermic circulatory arrest. Eur J Cardiothorac Surg (2012) 1.50
Effect of rectal distention on lower urinary tract function in children. J Urol (2010) 1.46
Functional defecation disorders in children with lower urinary tract symptoms. J Urol (2012) 1.46
Lubiprostone for the treatment of functional constipation in children. J Pediatr Gastroenterol Nutr (2014) 1.45
CT and 99mTc-WBC vs colonoscopy in the evaluation of inflammation and complications of inflammatory bowel diseases. J Gastroenterol (2002) 1.44
Dose response of PEG 3350 for the treatment of childhood fecal impaction. J Pediatr (2002) 1.40
Gastric suction in newborns: guilty as charged or innocent bystander? J Pediatr (2004) 1.39
Physical and emotional health of mothers of youth with functional abdominal pain. Arch Pediatr Adolesc Med (2007) 1.38
Health utilization and cost impact of childhood constipation in the United States. J Pediatr (2008) 1.24
Citalopram treatment of pediatric recurrent abdominal pain and comorbid internalizing disorders: an exploratory study. J Am Acad Child Adolesc Psychiatry (2004) 1.22
Lower esophageal sphincter relaxation reflex kinetics: effects of peristaltic reflexes and maturation in human premature neonates. Am J Physiol Gastrointest Liver Physiol (2010) 1.20
Eosinophilic esophagitis: strictures, impactions, dysphagia. Dig Dis Sci (2003) 1.17
Constipation in childhood. Nat Rev Gastroenterol Hepatol (2011) 1.16
Colonic manometry as predictor of cecostomy success in children with defecation disorders. J Pediatr Surg (2006) 1.12
Post-infectious functional gastrointestinal disorders in children. J Pediatr (2008) 1.05
PEG3350 in the treatment of childhood constipation: a multicenter, double-blinded, placebo-controlled trial. J Pediatr (2008) 1.03
Giant metastatic myxoid liposarcoma of the mediastinum: a case report. J Thorac Cardiovasc Surg (2005) 1.01
Cecostomy in children with defecation disorders. Dig Dis Sci (2006) 0.99
A prospective community-based study of gastroenterological symptoms in school-age children. J Pediatr Gastroenterol Nutr (2006) 0.97
Internal anal sphincter achalasia in children: clinical characteristics and treatment with Clostridium botulinum toxin. J Pediatr Gastroenterol Nutr (2003) 0.96
Long-term outcome of congenital intestinal pseudoobstruction. Dig Dis Sci (2002) 0.95
Evaluation and management of neonatal dysphagia: impact of pharyngoesophageal motility studies and multidisciplinary feeding strategy. J Pediatr Gastroenterol Nutr (2009) 0.93
Pharmacotherapy for functional gastrointestinal disorders in children. J Pediatr Gastroenterol Nutr (2009) 0.89
Adolescent constipation: evaluation and management. Adolesc Med Clin (2004) 0.89
Accuracy of pain recall in children. J Pediatr Gastroenterol Nutr (2012) 0.88
Colonic hyperactivity results in frequent fecal soiling in a subset of children after surgery for Hirschsprung disease. J Pediatr Gastroenterol Nutr (2011) 0.88
Antegrade enemas for defecation disorders: do they improve the colonic motility? J Pediatr Surg (2009) 0.86
Is there a role for surgery beyond colonic aganglionosis and anorectal malformations in children with intractable constipation? J Pediatr Surg (2004) 0.86
Interobserver and intraobserver reliability of the Rome II criteria in children. Am J Gastroenterol (2005) 0.86
Colonic dysmotility in constipation. Best Pract Res Clin Gastroenterol (2011) 0.86
Wireless motility capsule test in children with upper gastrointestinal symptoms. J Pediatr (2013) 0.85
Ten-year experience using antegrade enemas in children. J Pediatr (2012) 0.85
Constipation and colonic transit times in children with morbid obesity. J Pediatr Gastroenterol Nutr (2011) 0.85
Novel techniques to study colonic motor function in children. Curr Gastroenterol Rep (2013) 0.85
Overview of pediatric gastroesophageal reflux disease and proton pump inhibitor therapy. J Pediatr Gastroenterol Nutr (2003) 0.84
Pediatric patients with dyspepsia have chronic symptoms, anxiety, and lower quality of life as adolescents and adults. Gastroenterology (2012) 0.84
How reliable are the Rome III criteria for the assessment of functional gastrointestinal disorders in children? Am J Gastroenterol (2010) 0.84
Functional defecation disorders in children: comparing the Rome II with the Rome III criteria. J Pediatr (2012) 0.84
Effect of Nissen fundoplication on gastric motor and sensory functions. J Pediatr Gastroenterol Nutr (2006) 0.83
Evaluation of mucosal eosinophils in the pediatric colon. Dig Dis Sci (2005) 0.82
Functional abdominal pain: time to get together and move forward. J Pediatr Gastroenterol Nutr (2008) 0.82
Pediatric eosinophilic esophagitis: radiologic findings with pathologic correlation. Pediatr Radiol (2009) 0.82
Prevalence of pain-predominant functional gastrointestinal disorders and somatic symptoms in patients with anxiety or depressive disorders. J Pediatr (2013) 0.82
Management of intractable constipation with antegrade enemas in neurologically intact children. J Pediatr Gastroenterol Nutr (2002) 0.82
Children with cystic fibrosis have prolonged chemical clearance of acid reflux compared to symptomatic children without cystic fibrosis. Dig Dis Sci (2013) 0.81
Gastroesophageal reflux causing sleep interruptions in infants. J Pediatr Gastroenterol Nutr (2013) 0.81
Bowel habits and toilet training in a diverse population of children. J Pediatr Gastroenterol Nutr (2009) 0.81
Motility disorders. Diagnosis and treatment for the pediatric patient. Pediatr Clin North Am (2002) 0.81
Infant crying, colic, and gastrointestinal discomfort in early childhood: a review of the evidence and most plausible mechanisms. J Pediatr Gastroenterol Nutr (2013) 0.81
Effect of nutritional rehabilitation on gastric motility and somatization in adolescents with anorexia. J Pediatr (2013) 0.81
Oral prucalopride in children with functional constipation. J Pediatr Gastroenterol Nutr (2013) 0.80
Pharmacotherapy for functional gastrointestinal disorders in children. Curr Opin Pharmacol (2006) 0.80
Colon cleansing with oral sodium phosphate in adolescents: dose, efficacy, acceptability, and safety. Am J Gastroenterol (2008) 0.80
Efficacy of permanent gastric electrical stimulation for the treatment of gastroparesis and functional dyspepsia in children and adolescents. J Pediatr Surg (2013) 0.79
Interobserver variability in the interpretation of colon manometry studies in children. J Pediatr Gastroenterol Nutr (2012) 0.79
Knowledge and practice styles of pediatricians in Saudi Arabia regarding childhood constipation. J Pediatr Gastroenterol Nutr (2013) 0.79
Assessment of abdominal pain through global outcomes and recent FDA recommendations in children: are we ready for change? J Pediatr Gastroenterol Nutr (2014) 0.79
Chemical clearance in infants and children with Acid reflux in the physiologic range. J Pediatr Gastroenterol Nutr (2015) 0.78
Severe pediatric rumination syndrome: successful interdisciplinary inpatient management. J Pediatr Gastroenterol Nutr (2011) 0.78
The care of constipated children in primary care in different countries. Acta Paediatr (2012) 0.78
Treatment Options for Refractory Childhood Constipation. Curr Treat Options Gastroenterol (2002) 0.78
Barostat testing in children with functional gastrointestinal disorders. Curr Gastroenterol Rep (2006) 0.78
Do some adolescents with rumination syndrome have "supragastric vomiting"? J Pediatr Gastroenterol Nutr (2010) 0.77
Functional abdominal pain: all roads lead to Rome (criteria). Pediatr Ann (2009) 0.77
The value of fluoroscopic defecography in the diagnostic and therapeutic management of defecation disorders in children. Pediatr Radiol (2014) 0.77
Beliefs and attitudes of general pediatricians and pediatric gastroenterologists regarding functional gastrointestinal disorders: a survey study. Clin Pediatr (Phila) (2011) 0.77
Functional Nausea in Children. J Pediatr Gastroenterol Nutr (2016) 0.76
Tegaserod use in children: a single-center experience. J Pediatr Gastroenterol Nutr (2008) 0.76
Cost and consultation patterns of abdominal pain in Uruguayan children. J Pediatr Gastroenterol Nutr (2008) 0.76
Measuring the symptoms of pediatric constipation and irritable bowel syndrome with constipation: expert commentary and literature review. Patient (2014) 0.76
Pediatric gastric and duodenal disorders. Curr Opin Gastroenterol (2004) 0.76
Postfundoplication Complications in Children. Curr Treat Options Gastroenterol (2001) 0.76
Authors' response. J Pediatr Gastroenterol Nutr (2014) 0.75
Authors' response. J Pediatr Gastroenterol Nutr (2014) 0.75
Probiotics for abdominal pain disorders in children--safe to use but are they helpful? Nat Clin Pract Gastroenterol Hepatol (2007) 0.75
Effect of colon transection on spontaneous and meal-induced high-amplitude--propagating contractions in children. J Pediatr Gastroenterol Nutr (2015) 0.75
Interventional radiology in the treatment of the complications of organ transplant in the pediatric population-part 1: the kidneys, heart, lungs, and intestines. Semin Intervent Radiol (2004) 0.75
Gastroesophageal reflux: not a time to "relax". J Pediatr (2006) 0.75
Lack of Agreement on How to Use Antegrade Enemas in Children. J Pediatr Gastroenterol Nutr (2016) 0.75
Effect of amoxicillin/clavulanate on gastrointestinal motility in children. J Pediatr Gastroenterol Nutr (2012) 0.75
Adolescent rumination syndrome. Pediatr Ann (2014) 0.75
How do antegrade enemas work? Colonic motility in response to administration of normal saline solution into the proximal colon. J Pediatr Gastroenterol Nutr (2010) 0.75
Index of suspicion. Pediatr Rev (2005) 0.75
Pancreatic ascites in an infant: lack of symptoms and normal amylase. Dig Dis Sci (2003) 0.75
Do We Really Need Soap to Clean the Rectum? J Pediatr Gastroenterol Nutr (2016) 0.75
[Medico-surgical consensus for management of children with gastroesophageal reflux Acapulco, Mexico 2002]. Rev Gastroenterol Mex (2004) 0.75
Neurostimulation of the gastrointestinal tract in children: is it time to shock the gut? Curr Opin Pediatr (2016) 0.75